# C_2014396EN.01003001.xml

| 11.11.2014 | EN | Official Journal of the European Union | C 396/30 |
| --- | --- | --- | --- |

11.11.2014

EN

Official Journal of the European Union

C 396/30

---

Prior notification of a concentration

(Case M.7337 — IMS Health/Cegedim Business)

(Text with EEA relevance)

2014/C 396/07

| 1. | On 4 November 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking IMS Health (United States of America) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of part of the businesses of Cegedim SA (France) (‘the Cegedim Business’) by way of purchase of assets. |
| --- | --- |

1.

On 4 November 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking IMS Health (United States of America) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of part of the businesses of Cegedim SA (France) (‘the Cegedim Business’) by way of purchase of assets.

1

| 2. | The business activities of the undertakings concerned are:
  —   for IMS Health: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries,
  —   Cegedim Business: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for IMS Health: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries,

for IMS Health

—   Cegedim Business: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries.

Cegedim Business

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7337 — IMS Health/Cegedim Business:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7337 — IMS Health/Cegedim Business:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---